Company / Total Assets
Arcus Biosciences, Inc. Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.1B
FY2025
5-year range
$1.1B / $1.6B
FY2021-FY2025
Trend
-1.0%
vs FY2024
Sector context
#73 of 214
Health Care
What the data says
At $1.1B, Arcus Biosciences, Inc.'s total assets ranks #73 of 214 in the Health Care sector. Total Assets has fluctuated over the past 9 years, ranging from $190M in FY2017 to $1.6B in FY2021.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +8.1%.
Improved from $1.1B to $1.1B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -5.4%
- 5-Year CAGR
- +8.1%
- 10-Year CAGR
- -
Sector benchmark
#73 of 214 in Health CareTop 34% of 214This company $1.1B Sector average $7.5B
▼
-84.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.1%, indicating consistent growth.
- In FY2025, total assets decreased 1.0% year-over-year.
- Ranks #73 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | -1.0% |
| FY2024 | $1.1B | +5.0% |
| FY2023 | $1.1B | -18.6% |
| FY2022 | $1.3B | -15.5% |
| FY2021 | $1.6B | +106.1% |
| FY2020 | $772.3M | +280.2% |
| FY2019 | $203.1M | -26.1% |
| FY2018 | $274.9M | +44.3% |
| FY2017 | $190.5M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026